Following the hospital course of a patient that suffers from osteomyelitis gives but a glimpse of its crushing toll, both on the patient’s health and ability. The inflammation or swelling of the bone tissue is usually the result of an infection, and the culprits are many. Osteomyelitis has many faces, and therefore calls for multifaceted solutions.

When you are facing critical decisions about your osteomyelitis pipeline, you need both robust, relevant models and the expertise to design your studies to provide certain answers. That is when you turn to PharmaLegacy.Our expertise in pharmacology is unmatched: with a team of experts that has been in the field for almost two decades now, developing innovative models for you to use in your studies.

Your pipelines can’t wait, and PharmaLegacy is at the ready. Contact us now and we’ll get to work.